BeStock  
Stocks › Medical Devices › QDEL

QuidelOrtho QDEL

US equityMarket cap rank #3517Medical Devices
$8.32 −$0.60 (-6.73%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $8.35 +0.36%
Open$8.95
Prev close$8.92
Day range$8.06 – $8.95
Volume2.61M
Market cap$570.86M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership120.4%-1.82 pts vs. prior quarter
Institutions holding272-16 vs. prior quarter
Insider trades (recent)43 buys / 7 sellsNet buying
Short interest21.09% of floatDays to cover 7.6 · as of 30 Oct 2026
Short-sale volume share19.8%5-day average of daily volume

Short-sale volume as % of daily volume

6%13%21%28%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.84M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$7.2MSuper−$3.6MBig−$3.4MMid−$849.0KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 42.7% of shares outstanding.

Largest holders

  • BlackRock16.24%
  • Newtyn Management, LLC9.66%
  • FMR5.76%
  • American Century Investment Management5.72%
  • Vanguard Portfolio Management, LLC5.30%
  • Neuberger Berman Investment Advisers LLC4.93%
  • Rubric Capital Management LP4.82%
  • Invesco Ltd.4.48%

By investor type

  • Mutual Fund90.46%
  • Hedge Fund22.25%
  • Public Company5.14%
  • Government Pension Fund1.16%
  • Individual/Insider1.14%
  • Private Company0.78%
  • Insurance Company0.35%
  • Family Office/Trust0.22%

Reported short interest has fallen from 21.82% to 21.09% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
American Century Investment Management Mutual Fund 2026/Q3 +619,555 5.7%
Thompson, Siegel & Walmsley LLC Mutual Fund 2026/Q3 +309,366 1.1%
Citigroup Inc. Public Company 2026/Q3 +294,576 0.5%
Morgan Stanley Public Company 2026/Q3 +271,442 2.8%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +271,442 2.8%
Gagnon Securities, LLC Mutual Fund 2026/Q3 +268,191 1.9%
Edgestream Partners, L.P. Hedge Fund 2026/Q3 +227,506 0.7%
Private Management Group Inc Mutual Fund 2026/Q3 +219,908 3.3%
Gagnon Advisors, LLC Hedge Fund 2026/Q3 +191,089 0.6%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +186,662 0.3%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +114,484 0.5%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +98,390 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +184,116 0.3%
Newtyn Management, LLC Hedge Fund 2026/Q3 +2,066,528 9.7%
Paradigm Capital Management, Inc. Mutual Fund 2026/Q3 +995,800 3.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Oct 2026 Jonathan Siegrist Head of Point of Care Diagnostics Derivative Exercise and Sale -6,695 $13.91 25,381
14 Oct 2026 Jonathan Siegrist Head of Point of Care Diagnostics Derivative Exercise and Retained +11,962 – 25,381
14 Sep 2026 Ronald Bowman Chief Human Resources Officer Derivative Exercise and Sale -921 $10.63 5,020
14 Sep 2026 Ronald Bowman Chief Human Resources Officer Derivative Exercise and Retained +1,645 – 5,020
14 Aug 2026 Bryan Hanson Head of Core Diagnostics Derivative Exercise and Sale -162 $14.30 8,055
14 Aug 2026 Bryan Hanson Head of Core Diagnostics Derivative Exercise and Retained +284 – 8,055
14 Jul 2026 Micah Young Chief Financial Officer & Principal Financial Officer Other Derivative Acquisition +356,555 – 356,555
30 Jun 2026 Bryan Hanson Head of Core Diagnostics Derivative Exercise and Sale -2,096 $18.18 7,771
30 Jun 2026 Bryan Hanson Head of Core Diagnostics Derivative Exercise and Retained +3,701 – 7,771
24 Jun 2026 Ann Rhoads Independent Director Other Derivative Acquisition +369 – 369
24 Jun 2026 Ann Rhoads Independent Director Other Derivative Acquisition +3,698 – 3,698
24 Jun 2026 Ann Rhoads Independent Director Other Derivative Acquisition +15,532 – 15,532
24 Jun 2026 Kenneth Widder Independent Director Other Derivative Acquisition +1,997 – 1,997
24 Jun 2026 Kenneth Widder Independent Director Other Derivative Acquisition +6,656 – 6,656
24 Jun 2026 Kenneth Widder Independent Director Other Derivative Acquisition +15,532 – 15,532
24 Jun 2026 Kenneth Buechler Independent Non-Executive Chairperson Other Derivative Acquisition +3,661 – 3,661
24 Jun 2026 Kenneth Buechler Independent Non-Executive Chairperson Other Derivative Acquisition +12,204 – 12,204
24 Jun 2026 Kenneth Buechler Independent Non-Executive Chairperson Other Derivative Acquisition +15,532 – 15,532
24 Jun 2026 Edward Michael Independent Director Other Derivative Acquisition +1,053 – 1,053
24 Jun 2026 Edward Michael Independent Director Other Derivative Acquisition +3,513 – 3,513

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 14,464,172 21.1% 7.6
15 Oct 2026 12,991,571 18.9% 4.9
30 Sep 2026 14,953,442 21.8% 11.0
15 Sep 2026 14,190,525 20.7% 10.8
31 Aug 2026 14,128,210 20.6% 10.5
14 Aug 2026 14,962,267 21.8% 7.6

Discussion

No comments yet — be the first to weigh in on QDEL.

Sign in to join the discussion.

Scroll to Top